Allopregnanolone as a Regenerative Treatment for Parkinson's Disease

Clinical trial NCT06263010 · COMPLETED

Trial details

NCT number: NCT06263010
Sponsor: Roberta Brinton
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2024-01-12
Primary completion: 2025-07-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.